Economic Evaluation of Population-Based

BRCA breast cancer cancer prevention cost-effectiveness ovarian cancer population testing

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
17 Jul 2020
Historique:
received: 07 06 2020
revised: 07 07 2020
accepted: 13 07 2020
entrez: 26 7 2020
pubmed: 28 7 2020
medline: 28 7 2020
Statut: epublish

Résumé

Clinical criteria/Family history-based

Identifiants

pubmed: 32708835
pii: cancers12071929
doi: 10.3390/cancers12071929
pmc: PMC7409094
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Eve Appeal
ID : EMSG1K9R
Organisme : Cancer Research UK
ID : C569/A16891
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Références

JAMA. 2006 Jul 12;296(2):185-92
pubmed: 16835424
BMC Cancer. 2006 Aug 17;6:210
pubmed: 16916448
Cost Eff Resour Alloc. 2003 Dec 19;1(1):8
pubmed: 14687420
Health Policy. 2016 Mar;120(3):246-51
pubmed: 26851991
BJOG. 2011 Jun;118(7):814-24
pubmed: 21392246
Ann Oncol. 2016 Apr;27(4):575-90
pubmed: 26646754
J Med Genet. 2016 Jul;53(7):472-80
pubmed: 26993268
Eur J Cancer. 2007 Jul;43(10):1548-55
pubmed: 17321736
Clin Genet. 2010 Nov;78(5):411-7
pubmed: 20653694
J Clin Oncol. 2006 May 1;24(13):2028-37
pubmed: 16648502
J Clin Oncol. 2017 Dec 1;35(34):3800-3806
pubmed: 28820644
J Clin Oncol. 2009 May 20;27(15):2466-73
pubmed: 19349544
J Clin Oncol. 2004 Mar 15;22(6):1055-62
pubmed: 14981104
N Engl J Med. 2014 Aug 28;371(9):796-7
pubmed: 25162885
J Mammary Gland Biol Neoplasia. 2005 Apr;10(2):169-80
pubmed: 16025223
Bull World Health Organ. 2016 Dec 1;94(12):925-930
pubmed: 27994285
Lancet. 2005 May 21-27;365(9473):1769-78
pubmed: 15910949
J Med Genet. 2018 Aug;55(8):538-545
pubmed: 29622727
Br J Cancer. 2009 Aug 4;101(3):395-402
pubmed: 19603016
Value Health. 2005 Jan-Feb;8(1):1-2
pubmed: 15841888
Clin Cardiol. 2015 Jan;38(1):13-9
pubmed: 25336401
Best Pract Res Clin Obstet Gynaecol. 2020 May;65:46-65
pubmed: 32192936
Breast Cancer Res Treat. 2011 Feb;125(3):837-47
pubmed: 20644999
J Clin Oncol. 2010 Jan 20;28(3):387-91
pubmed: 20008623
Cancer. 2017 May 15;123(10):1721-1730
pubmed: 28085182
JAMA. 2019 Aug 20;322(7):652-665
pubmed: 31429903
J Clin Oncol. 2008 Mar 10;26(8):1331-7
pubmed: 18268356
N Engl J Med. 2007 Jul 12;357(2):115-23
pubmed: 17625123
J Natl Cancer Inst. 2013 Jan 16;105(2):141-8
pubmed: 23257159
Lancet Oncol. 2015 Jan;16(1):67-75
pubmed: 25497694
Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1458-68
pubmed: 22744338
J Clin Oncol. 2012 Dec 10;30(35):4447-8
pubmed: 23091104
Breast Cancer Res Treat. 2010 Jan;119(1):177-84
pubmed: 19322653
Hum Mutat. 2008 Nov;29(11):1282-91
pubmed: 18951446
Genet Med. 2017 Jul;19(7):754-762
pubmed: 27929526
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
JAMA Oncol. 2018 Nov 1;4(11):1553-1568
pubmed: 29860482
Lancet. 2005 May 14-20;365(9472):1687-717
pubmed: 15894097
Br J Cancer. 2019 Jul;121(1):15-21
pubmed: 30971774
J Med Genet. 2015 Jul;52(7):465-75
pubmed: 26025000
JAMA. 2019 Sep 3;322(9):868-886
pubmed: 31479143
Health Technol Assess. 2011 Sep;15(34):v-vi, 1-322
pubmed: 21951942
Cancer. 2005 Oct 15;104(8):1742-50
pubmed: 16149088
JAMA. 2016 Sep 13;316(10):1093-103
pubmed: 27623463
Clin Genet. 2014 Sep;86(3):229-37
pubmed: 24304220
Ann Surg Oncol. 2013 Dec;20(13):4113-20
pubmed: 23868655
Lancet. 2013 May 25;381(9880):1827-34
pubmed: 23639488
J Natl Cancer Inst. 2009 Jan 21;101(2):80-7
pubmed: 19141781
J Natl Cancer Inst. 2014 Nov 30;107(1):379
pubmed: 25435541
Womens Health (Lond). 2009 Sep;5(5):497-502
pubmed: 19702449
Arch Intern Med. 2003 Jul 28;163(14):1637-41
pubmed: 12885677
J Clin Oncol. 2019 Feb 20;37(6):453-460
pubmed: 30526229
Semin Surg Oncol. 2000 Jun;18(4):287-95
pubmed: 10805950
Value Health. 2016 Dec;19(8):929-935
pubmed: 27987642
Annu Rev Genomics Hum Genet. 2020 Apr 21;:
pubmed: 32315550
Eur J Cancer. 2007 Jul;43(11):1713-7
pubmed: 17574839
J Natl Cancer Inst. 2014 Nov 30;107(1):380
pubmed: 25435542
Obstet Gynecol. 2013 Apr;121(4):709-16
pubmed: 23635669
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
J Community Genet. 2020 Jul;11(3):291-302
pubmed: 31879826
ESMO Open. 2018 Apr 13;3(3):e000328
pubmed: 29682331
Gynecol Oncol. 2009 May;113(2):216-20
pubmed: 19217148
BJOG. 2020 Feb;127(3):364-375
pubmed: 31507061
BJOG. 2012 Apr;119(5):527-36
pubmed: 22260402
Cancers (Basel). 2018 Nov 05;10(11):
pubmed: 30400647
J Clin Oncol. 2014 Mar 1;32(7):618-26
pubmed: 24449235
Value Health. 2012 May;15(3):429-36
pubmed: 22583452
Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14205-10
pubmed: 25192939
Sci Rep. 2016 Jul 13;6:29506
pubmed: 27406733
Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2318-24
pubmed: 19661091
Breast Cancer Res Treat. 2010 Jan;119(1):13-24
pubmed: 19789974
Breast Cancer Res Treat. 2011 Aug;129(1):185-90
pubmed: 21394499
Cad Saude Publica. 2018 Jun 21;34(6):e00097018
pubmed: 29947658
PLoS One. 2017 Oct 20;12(10):e0186043
pubmed: 29053726
N Engl J Med. 2003 Jan 2;348(1):50-8
pubmed: 12510043
Health Econ. 2016 Feb;25 Suppl 1:29-41
pubmed: 26775571
Arch Gerontol Geriatr. 2018 Nov - Dec;79:32-38
pubmed: 30086414
Breast Cancer Res. 2004;6(1):R8-R17
pubmed: 14680495
JAMA. 2019 Aug 20;322(7):666-685
pubmed: 31429902
Ann Intern Med. 2014 Feb 18;160(4):255-66
pubmed: 24366442
Menopause Int. 2010 Jun;16(2):60-4
pubmed: 20729495

Auteurs

Ranjit Manchanda (R)

Wolfson Institute for Preventive Medicine, CRUK Barts Cancer Centre, Queen Mary University of London, London EC1M 6BQ, UK.
Department of Gynaecological Oncology, Barts Health NHS Trust, Royal London Hospital, London E1 1BB, UK.
MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, Faculty of Population Health Sciences, University College London, London WC1V 6LJ, UK.

Li Sun (L)

Wolfson Institute for Preventive Medicine, CRUK Barts Cancer Centre, Queen Mary University of London, London EC1M 6BQ, UK.
Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London WC1H 9SH, UK.

Shreeya Patel (S)

Wolfson Institute for Preventive Medicine, CRUK Barts Cancer Centre, Queen Mary University of London, London EC1M 6BQ, UK.

Olivia Evans (O)

Wolfson Institute for Preventive Medicine, CRUK Barts Cancer Centre, Queen Mary University of London, London EC1M 6BQ, UK.
Department of Gynaecological Oncology, Barts Health NHS Trust, Royal London Hospital, London E1 1BB, UK.

Janneke Wilschut (J)

Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, Netherlands.

Ana Carolina De Freitas Lopes (AC)

Departamento de Medicina Preventiva, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, 01246903 Sao Paulo, Brazil.

Faiza Gaba (F)

Wolfson Institute for Preventive Medicine, CRUK Barts Cancer Centre, Queen Mary University of London, London EC1M 6BQ, UK.
Department of Gynaecological Oncology, Barts Health NHS Trust, Royal London Hospital, London E1 1BB, UK.

Adam Brentnall (A)

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London EC1M 6BQ, UK.

Stephen Duffy (S)

Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London EC1M 6BQ, UK.

Bin Cui (B)

School of Public Health, Peking University, Beijing 100191, China.

Patricia Coelho De Soarez (P)

Departamento de Medicina Preventiva, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, 01246903 Sao Paulo, Brazil.

Zakir Husain (Z)

Department of Humanities & Social Sciences, Indian Institute of Technology, Kharagpur, West Bengal 721302, India.
Department of Economics, Presidency University, Kolkata 700073, India.

John Hopper (J)

Centre for Epidemiology & Biostatistics, Melbourne School of Population & Global Health, Faculty of Medicine, Dentistry & Health Sciences, University of Melbourne, Victoria 3010, Australia.

Zia Sadique (Z)

Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London WC1H 9SH, UK.

Asima Mukhopadhyay (A)

Tata Medical Centre, Kolkata, West Bengal 700160, India.
Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Li Yang (L)

School of Public Health, Peking University, Beijing 100191, China.

Johannes Berkhof (J)

Department of Epidemiology and Biostatistics, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HV Amsterdam, Netherlands.

Rosa Legood (R)

Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London WC1H 9SH, UK.

Classifications MeSH